Press-release for stocks for snynf

symbols : Snynf crawled time : 11:00

save search

Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -0.22% | O: -0.53% H: 0.61% C: 0.61%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -0.21% | O: -0.04% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 1.28% | O: 0.13% H: 0.11% C: -1.73%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| 0.71% | O: 1.95% H: 0.0% C: 0.0%
research global gastrointestinal therapeutics

IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -2.59% | O: -0.32% H: 0.0% C: 0.0%
IGMS | $7.2 -2.83% -2.92% 220K

Health Technology

| -18.37% | O: -0.91% H: 0.0% C: -6.41%

Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -2.59% | O: -0.32% H: 0.0% C: 0.0%
NRIX | $13.6 -5.82% -6.18% 1M

Health Technology

| -3.51% | O: 18.35% H: 1.98% C: -5.88%
first update therapeutics financial results

MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
MLTX | $42.19 -0.14% -0.14% 530K

| -10.06% | O: -2.03% H: 2.45% C: 0.48%
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -2.59% | O: -0.32% H: 0.0% C: 0.0%
partnership health research technology skin

Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6
Published: 2024-04-09 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.38% | O: 0.28% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -2.16% | O: -0.38% H: 0.95% C: 0.83%
NRIX | $13.6 -5.82% -6.18% 1M

Health Technology

| -2.3% | O: 1.26% H: 0.0% C: 0.0%
protein collaboration extension therapeutics sanofi

Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Published: 2024-04-05 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -3.54% | O: -1.77% H: 0.0% C: -1.81%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -4.72% | O: -3.44% H: 0.0% C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K

Health Technology

| -2.4% | O: -0.4% H: 0.0% C: -5.22%
pharma report universal

XORTX Announces New Clinical Advisory Board Member - March 27, 2024
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -7.26% | O: -0.26% H: 0.0% C: 0.0%
XRTX | $3.5 -3.05% -3.14% 12K

Mining, Quarrying, and Oil and ...

| 1.84% | O: 0.0% H: 0.0% C: -5.79%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -5.89% | O: 1.06% H: 0.0% C: 0.0%

Regeneron Provides Update on Biologics License Application for Odronextamab
Published: 2024-03-25 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.09% | O: -100.0% H: NaN% C: Infinity%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -3.68% | O: 0.42% H: 0.0% C: 0.0%
REGN | $896.27 0.26% 0.25% 500K

Health Technology

| -7.28% | O: -1.37% H: 1.15% C: 0.74%
license update application

Bavarian Nordic A/S – Notice Convening Annual General Meeting
Published: 2024-03-21 (Crawled : 11:00) - globenewswire.com
GNMSF | $290.38 3.83% 220

Health Technology

| -1.78% | O: 0.03% H: 3.03% C: 1.75%
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -2.29% | O: 0.14% H: 0.24% C: 0.24%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -4.93% | O: -0.03% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -2.16% | O: 0.3% H: 0.0% C: 0.0%
NTLA | $21.57 1.17% 1.16% 1.4M

Health Technology

| -22.35% | O: 2.12% H: 0.6% C: -2.54%
GMAB | $28.72 1.38% 1.36% 360K

Health Technology

| -2.51% | O: 1.19% H: 0.47% C: -0.77%
meeting

Praluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -3.66% | O: 0.57% H: 0.0% C: 0.0%
REGN | $896.27 0.26% 0.25% 500K

Health Technology

| -7.43% | O: 0.23% H: 0.9% C: -0.68%
praluent fda children genetic cholesterol approval treat injection

FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -3.66% | O: 0.57% H: 0.0% C: 0.0%
FGEN | $1.15 -1.71% -1.74% 1.3M

Health Technology

| -36.11% | O: -1.67% H: 3.95% C: -3.39%
medical

Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published: 2024-03-06 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.01% | O: 0.0% H: 0.8% C: 0.8%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -2.63% | O: -0.45% H: 0.0% C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K

Health Technology

| -5.06% | O: 0.78% H: 1.93% C: 0.97%
iph45 pharma drug antibody preclinical

Linvoseltamab Receives EMA Filing Acceptance for Treatment of Relapsed/Refractory Multiple Myeloma
Published: 2024-02-02 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -4.46% | O: -0.93% H: 0.0% C: 0.0%
REGN | $896.27 0.26% 0.25% 500K

Health Technology

| -6.36% | O: 1.4% H: 0.28% C: -2.68%
treatment ema

Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Published: 2024-01-12 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology